Volvo announces executive board changes effective September

Pär Boman Chairman of the Board Volvo Group
Pär Boman Chairman of the Board - Volvo Group
0Comments

Lars Stenqvist, a member of the Volvo Group Executive Board and Group Chief Technology Officer, will step down from his current role after nine years. He will remain with the company as a senior leader. Jens Holtinger, currently an Executive Board member and Executive Vice President of Group Trucks Operations, will succeed him.

“Lars, in his leadership role, has been instrumental in the Group’s positive development and a pioneer on the journey towards more sustainable transport. I deeply value the significant contributions he has made over the years,” said Martin Lundstedt, President and CEO.

Jens Holtinger brings over 25 years of experience within the Volvo Group to his new position. His previous roles include overseeing truck manufacturing in Europe and Brazil and managing various truck production plants.

“With his extensive experience across the entire value chain, Jens will bring valuable perspectives that support our continued focus on innovation and operational excellence. His steady leadership and industry insight will be important as we continue to develop solutions that meet evolving needs,” added Martin Lundstedt.

The transition is set for September 1st, 2025.

The Volvo Group offers transport and infrastructure solutions worldwide. Established in 1927, it is headquartered in Gothenburg, Sweden. The company employs over 100,000 people globally and reported net sales of SEK 527 billion (EUR 46 billion) in 2024.

For further information or media inquiries, contact Claes Eliasson at +46 76 553 7229 or [email protected].



Related

Paul Hudson Chief Executive Officer Sanofi SA

Acoziborole receives key EU panel backing as single-dose treatment for sleeping sickness

Acoziborole Winthrop, a new oral treatment for sleeping sickness developed by the Drugs for Neglected Diseases initiative (DNDi) and Sanofi, has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for…

Martin Lundstedt President and CEO at Volvo Group North America LLC Volvo Group North America LLC

Volvo announces updated share and vote count after series conversion

The number of votes in AB Volvo has changed following the conversion of 2,000,619 Series A shares into an equal number of Series B shares.

Paul Hudson Chief Executive Officer Sanofi SA

Sanofi and Regeneron’s Dupixent recommended for EU approval in young children with chronic urticaria

Sanofi and Regeneron have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Dupixent (dupilumab) for children aged two to 11 years with…

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from EU Business Daily.